Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.794 USD | +0.13% | -9.98% | -16.61% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company shows low valuation levels, with an enterprise value at 0.24 times its sales.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Managed Healthcare
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.61% | 393M | - | ||
+9.96% | 121B | A- | ||
+21.29% | 103B | B- | ||
-24.27% | 42.13B | A- | ||
+5.75% | 41.91B | B- | ||
+13.71% | 24.52B | B- | ||
+2.61% | 3.67B | C+ | ||
-42.39% | 905M | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock
- Equities
- Stock Clover Health Investments, Corp. - Nasdaq
- Ratings Clover Health Investments, Corp.